Recent Updates
Recently added Catalysts
RADX Neutral Sentiment Score: 60/100

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Update Summary Entity name RADIOPHARM THERANOSTICS LIMITED Announcement Type Update to previous announcement Date of this announ

Key Takeaway: Radiopharm Theranostics Limited issued an update announcing the issuance of various unquoted equity securities under an employee incentive scheme. The announcement includes details on types, numbers, and existing classes of the securities, noting some are intended to remain unquoted on the ASX. The update serves to clarify information related to a previous announcement regarding these securities.

Market Sentiment Analysis

Full Press Release Details

RADIOPHARM THERANOSTICS LIMITED
Update to previous announcement
Date of this announcement
Friday March 07, 2025
Reason for the update
Refer to next page for full details of the announcement
RADIOPHARM THERANOSTICS LIMITED
We (the entity named above) give notice of the issue, conversion
or payment up of the following unquoted +securities.
1.2 Registered number type Registration number
ACN 647877889
Update/amendment to previous announcement
for update to a previous announcement
b Date of previous announcement to this update
Date of this announcement
The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme
that are not intended to be quoted on ASX
2.2a This notification is
given in relation to an issue of +securities in a class which is not quoted on ASX and which:
has an existing ASX security code ("existing class")
Part 3B - number and type of +securities
the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B
ASX +security code and description
RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Date the +securities the subject of this notification
Will these +securities rank equally in all respects
from their issue date with the existing issued +securities in that class
Were any of the +securities issued to +key management
personnel (KMP) or an +associate?
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme
or a summary of the terms
Any other information the entity wishes to provide
about the +securities the subject of this notification
Number of +securities
Following the issue, conversion or payment up of
the +securities the subject of this notification, the +securities of the entity will comprise:
The figures in parts
4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix
3G or Appendix 3H forms are currently with ASX for processing.
Quoted +securities (Total number of each +class of +securities issued and quoted on ASX)
Total number of
ASX +security code and description +securities on issue
RADO : OPTION EXPIRING 30-NOV-2026 79,352,040
RAD : ORDINARY FULLY PAID 2,333,980,142
RADOA : OPTION EXPIRING 24-AUG-2026 818,890,534
Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
RADAK : OPTION EXPIRING 01-JUN-2027 EX $0.60 1,666,500
RADAE : OPTION EXPIRING 25-NOV-2025 RESTRICTED 5,700,006
RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 209,716,866
RADAJ : OPTION EXPIRING 01-JUL-2027 EX $0.17 13,137,976
RADAF : OPTION EXPIRING 25-NOV-2026 RESTRICTED 8,666,678
RADAG : OPTION EXPIRING 25-NOV-2026 EX $0.60 5,066,672
RADAH : OPTION EXPIRING 22-DEC-2025 EX $0.60 400,000
RADAI : OPTION EXPIRING 27-MAY-2027 EX $0.60 740,000
RADAP : OPTION EXPIRING 24-APR-2028 EX $0.09 8,955,224
5.1 Were the +securities issued
under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1?
Select the number of the applicable exception in Listing Rule 7.2

Frequently Asked Questions

What is the date of the latest announcement for Radiopharm?

The latest announcement for Radiopharm was made on March 7, 2025.

What type of securities were issued by Radiopharm?

Radiopharm issued unquoted securities under an employee incentive scheme.

How many quoted ordinary shares does Radiopharm have?

Radiopharm has 2,333,980,142 quoted ordinary shares.

What is the total number of unquoted options by Radiopharm?

Radiopharm has a total of 209,716,866 unquoted options.

Did the securities issue require security holder approval?

The securities were issued under an exception and did not require holder approval.

Last updated: Mar 7, 2025